Publicaciones en colaboración con investigadores/as de Leiden University Medical Center (6)

2023

  1. Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party

    Bone Marrow Transplantation

2021

  1. Thiotepa–busulfan–fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT

    Bone Marrow Transplantation, Vol. 56, Núm. 7, pp. 1593-1602

2020

  1. Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

    Bone Marrow Transplantation, Vol. 55, Núm. 4, pp. 681-694

  2. Correction: Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) (Bone Marrow Transplantation, (2020), 55, 4, (681-694), 10.1038/s41409-019-0718-7)

    Bone Marrow Transplantation

2018

  1. Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: A retrospective study on behalf of the chronic malignancies working party of the EBMT

    Bone Marrow Transplantation, Vol. 53, Núm. 3, pp. 255-263

2017

  1. Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation

    Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380